Title |
Synthesis, pharmacokinetics, and biological use of lysine-modified single-walled carbon nanotubes
|
---|---|
Published in |
International Journal of Nanomedicine, September 2014
|
DOI | 10.2147/ijn.s66050 |
Pubmed ID | |
Authors |
J Justin Mulvey, Evan N Feinberg, Simone Alidori, Michael R McDevitt, Daniel A Heller, David A Scheinberg |
Abstract |
We aimed to create a more robust and more accessible standard for amine-modifying single-walled carbon nanotubes (SWCNTs). A 1,3-cycloaddition was developed using an azomethine ylide, generated by reacting paraformaldehyde and a side-chain-Boc (tert-Butyloxycarbonyl)-protected, lysine-derived alpha-amino acid, H-Lys(Boc)-OH, with purified SWCNT or C60. This cycloaddition and its lysine adduct provides the benefits of dense, covalent modification, ease of purification, commercial availability of reagents, and pH-dependent solubility of the product. Subsequently, SWCNTs functionalized with lysine amine handles were covalently conjugated to a radiometalated chelator, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA). The (111)In-labeled construct showed rapid renal clearance in a murine model and a favorable biodistribution, permitting utility in biomedical applications. Functionalized SWCNTs strongly wrapped small interfering RNA (siRNA). In the first disclosed deployment of thermophoresis with carbon nanotubes, the lysine-modified tubes showed a desirable, weak SWCNT-albumin binding constant. Thus, lysine-modified nanotubes are a favorable candidate for medicinal work. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 2% |
Unknown | 40 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 13 | 32% |
Student > Bachelor | 5 | 12% |
Student > Master | 5 | 12% |
Student > Doctoral Student | 4 | 10% |
Researcher | 3 | 7% |
Other | 5 | 12% |
Unknown | 6 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Chemistry | 9 | 22% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 12% |
Biochemistry, Genetics and Molecular Biology | 4 | 10% |
Engineering | 4 | 10% |
Agricultural and Biological Sciences | 3 | 7% |
Other | 8 | 20% |
Unknown | 8 | 20% |